183 related articles for article (PubMed ID: 3519969)
1. Synthesis and alpha-D-glucosidase inhibitory activity of N-substituted valiolamine derivatives as potential oral antidiabetic agents.
Horii S; Fukase H; Matsuo T; Kameda Y; Asano N; Matsui K
J Med Chem; 1986 Jun; 29(6):1038-46. PubMed ID: 3519969
[TBL] [Abstract][Full Text] [Related]
2. Valiolamine, a new alpha-glucosidase inhibiting aminocyclitol produced by Streptomyces hygroscopicus.
Kameda Y; Asano N; Yoshikawa M; Takeuchi M; Yamaguchi T; Matsui K; Horii S; Fukase H
J Antibiot (Tokyo); 1984 Nov; 37(11):1301-7. PubMed ID: 6392268
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of pseudo-aminosugars on oligosaccharide glucosidases I and II and on lysosomal alpha-glucosidase from rat liver.
Takeuchi M; Kamata K; Yoshida M; Kameda Y; Matsui K
J Biochem; 1990 Jul; 108(1):42-6. PubMed ID: 2229010
[TBL] [Abstract][Full Text] [Related]
4. Novel inhibitory effect of N-(2-hydroxycyclohexyl)valiolamine on melanin production in a human skin model.
Bin BH; Joo YH; Lee AY; Shin SS; Cho EG; Lee TR
Int J Mol Sci; 2014 Jul; 15(7):12188-95. PubMed ID: 25007819
[TBL] [Abstract][Full Text] [Related]
5. N-Substituted Valiolamine Derivatives as Potent Inhibitors of Endoplasmic Reticulum α-Glucosidases I and II with Antiviral Activity.
Karade SS; Hill ML; Kiappes JL; Manne R; Aakula B; Zitzmann N; Warfield KL; Treston AM; Mariuzza RA
J Med Chem; 2021 Dec; 64(24):18010-18024. PubMed ID: 34870992
[TBL] [Abstract][Full Text] [Related]
6. Naturally occurring sulfonium-ion glucosidase inhibitors and their derivatives: a promising class of potential antidiabetic agents.
Mohan S; Eskandari R; Pinto BM
Acc Chem Res; 2014 Jan; 47(1):211-25. PubMed ID: 23964564
[TBL] [Abstract][Full Text] [Related]
7. Stereoselective synthesis of new rac-quercitols containing hydroxymethyl groups as glucosidase inhibitors.
Aydin G; Savran T; Baran Ş; Baran A
Bioorg Med Chem Lett; 2018 Aug; 28(14):2555-2560. PubMed ID: 29866516
[TBL] [Abstract][Full Text] [Related]
8. Search for alpha-glucosidase inhibitors: new N-substituted valienamine and conduramine F-1 derivatives.
Łysek R; Schütz C; Favre S; O'Sullivan AC; Pillonel C; Krülle T; Jung PM; Clotet-Codina I; Esté JA; Vogel P
Bioorg Med Chem; 2006 Sep; 14(18):6255-82. PubMed ID: 16797996
[TBL] [Abstract][Full Text] [Related]
9. N-Arylmethylaminoquercitols, a new series of effective antidiabetic agents having α-glucosidase inhibition and antioxidant activity.
Worawalai W; Wacharasindhu S; Phuwapraisirisan P
Bioorg Med Chem Lett; 2015 Jun; 25(12):2570-3. PubMed ID: 25959812
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of 5a-carbaglycopyranosylamime glycosidase inhibitors.
Ogawa S; Kanto M
Curr Top Med Chem; 2009; 9(1):58-75. PubMed ID: 19199996
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of validamine, valienamine and valiolamine on activities of carbohydrases in rat small intestinal brush border membranes.
Takeuchi M; Takai N; Asano N; Kameda Y; Matsui K
Chem Pharm Bull (Tokyo); 1990 Jul; 38(7):1970-2. PubMed ID: 2268898
[TBL] [Abstract][Full Text] [Related]
12. [Synthesis, biological activity and molecular docking research of N-{[(4-oxo-thiochroman-3-yl)phenyl]-methyl}acetamide derivatives as α-glucosidase inhibitors].
Zhou G; Liang GC; Han XY; Zhong YF; Dong YF; Luo XC; Jin HW; Song YL
Yao Xue Xue Bao; 2016 Jan; 51(1):93-9. PubMed ID: 27405168
[TBL] [Abstract][Full Text] [Related]
13. Voglibose-inspired synthesis of new potent α-glucosidase inhibitors N-1,3-dihydroxypropylaminocyclitols.
Worawalai W; Sompornpisut P; Wacharasindhu S; Phuwapraisirisan P
Carbohydr Res; 2016 Jun; 429():155-62. PubMed ID: 27140506
[TBL] [Abstract][Full Text] [Related]
14. Novel inhibitory effect of the antidiabetic drug voglibose on melanogenesis.
Bin BH; Seo J; Yang SH; Lee E; Choi H; Kim KH; Cho EG; Lee TR
Exp Dermatol; 2013 Aug; 22(8):541-6. PubMed ID: 23879813
[TBL] [Abstract][Full Text] [Related]
15. Enzymatic synthesis of glucoside derivatives of validamine and valienamine.
Furumoto T; Kameda Y; Matsui K
Chem Pharm Bull (Tokyo); 1992 Jul; 40(7):1871-5. PubMed ID: 1394706
[TBL] [Abstract][Full Text] [Related]
16. Study on the synthesis and biological activities of α-substituted arylacetates derivatives.
Liu J; Chen C; Wu F; Tang J
Bioorg Med Chem Lett; 2016 Apr; 26(7):1715-9. PubMed ID: 26920798
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, in vitro evaluation and molecular docking studies of novel triazine-triazole derivatives as potential α-glucosidase inhibitors.
Wang G; Peng Z; Wang J; Li X; Li J
Eur J Med Chem; 2017 Jan; 125():423-429. PubMed ID: 27689725
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and in vitro α-glucosidase inhibition of novel dihydropyrano[3,2-c]quinoline derivatives as potential anti-diabetic agents.
Nikookar H; Mohammadi-Khanaposhtani M; Imanparast S; Faramarzi MA; Ranjbar PR; Mahdavi M; Larijani B
Bioorg Chem; 2018 Apr; 77():280-286. PubMed ID: 29421703
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and alpha-glucosidase-inhibiting activity of a new alpha-glucosidase inhibitor, 4-O-alpha-D-glucopyranosylmoranoline and its N-substituted derivatives.
Yoshikuni Y; Ezure Y; Seto T; Mori K; Watanabe M; Enomoto H
Chem Pharm Bull (Tokyo); 1989 Jan; 37(1):106-9. PubMed ID: 2655949
[TBL] [Abstract][Full Text] [Related]
20. Exploring the Dual Inhibitory Activity of Novel Anthranilic Acid Derivatives towards α-Glucosidase and Glycogen Phosphorylase Antidiabetic Targets: Design, In Vitro Enzyme Assay, and Docking Studies.
Ihmaid S
Molecules; 2018 May; 23(6):. PubMed ID: 29844263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
